Spero Therapeutics (SPRO) Tax Provisions (2023 - 2025)
Spero Therapeutics posted quarterly Tax Provisions of $261000.0 for Q4 2025, up 190.0% year-on-year from $90000.0 in Q4 2024, and up 190.0% on a QoQ basis from -$290000.0 in Q4 2024.
Spero Therapeutics (SPRO) has 3 years of Tax Provisions data on file, last reported at $261000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 190.0% year-over-year to $261000.0; the trailing twelve-month figure through Dec 2025 stood at $261000.0 (down 89.95% YoY), and the FY2025 full-year result was $261000.0, changed N/A from the prior year.
- Tax Provisions for Q4 2025 stood at $261000.0, up from -$290000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $2.2 million in Q3 2023 and bottomed at -$290000.0 in Q4 2024.
- The 3-year median for Tax Provisions is $290000.0 (2024), against an average of $571800.0.
- The widest annual swing landed in 2024, when Tax Provisions plunged 174.94%; it then surged 190.0% in 2025.
- A 3-year view of Tax Provisions shows it stood at $387000.0 in 2023, then sank by 174.94% to -$290000.0 in 2024, then soared by 190.0% to $261000.0 in 2025.
- The last three Tax Provisions figures came in at $261000.0 (Q4 2025), -$290000.0 (Q4 2024), and $290000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 261,000.00 |
| Dec 31, 2024 | -290,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 2.21 Mn |